Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
About this item
Full title
Author / Creator
Publisher
Tokyo: Frontiers Media SA
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Frontiers Media SA
Subjects
More information
Scope and Contents
Contents
Here, we present two patients with bronchial asthma, who developed keratosis pilaris (KP) following treatment with dupilumab, a monoclonal antibody to IL‐4 receptor. Both of them reported pruritic papules in their extremities in 1 months after initiation of dupilumab therapy. The lesions newly developed on the day of every administration of dupilum...
Alternative Titles
Full title
Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4710040ae2894f3f9200982a22409a58
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4710040ae2894f3f9200982a22409a58
Other Identifiers
ISSN
2574-4593
E-ISSN
2574-4593
DOI
10.1002/cia2.12172
